In the case of lymphomas, the oncolytic Ad vector LOAd703 expressing CD40L and 4-1BBL was combined with chimeric antigen receptor (CAR) T-cell therapy, demonstrating increased killing of lymphoma cell lines and lymphomas in xenograft mouse models [197]. Here, TNFSF9 is linked to lymphoma.